Infographics 19 Jan 2017
Infographic: A History of Approved Therapeutic Antibodies
Which are the EMA-approved therapeutic antibodies? How about their targets and indications? The number is growing year after year --…
Marie Godar
About
Ph.D. student – IWT-Baekeland doctoral researcher @argenx and IRC/VIB. Dual degree in Biotechnology: French engineering diploma at Polytech-Marseille + Master of Bioinformatics, Structural Biochemistry and Genomics at Aix-Marseille University.
Articles by Marie Godar
News and Trends 10 Oct 2016
Meet the French CEO who wants to Break Barriers to Drug Delivery
The objective of the French biotechnology company, Vect-Horus, is to leverage its technology, VECTrans, to facilitate the delivery of drugs into…
News and Trends 3 Oct 2016
Idriss J. Aberkane: Biomimetics could lead to the next Renaissance?
How can the observation of nature help us solve scientific, economic and social challenges? The French entrepreneur, Idriss J. Aberkane,…
News and Trends 19 Sep 2016
How Tech Transfer brings Science from the Bench to the Bedside
There are so many exciting discoveries in scientific research that could be used to cure, feed and fuel the world,…
ADVERTISEMENT
News and Trends 14 Apr 2016
Meet the CEO who wants to transform Pretty Corals into therapies for Cancer
The dream of Coral Biome in France is to use marine coral species to develop therapies against Cancer. We had…
News and Trends 11 Mar 2016
Interview: Can this Natural Acid replace Petroleum for the Chemical and Biofuel Industries?
GFBiochemicals in (Italy) is producing levulinic acid (from breakdown of biomass) to replace petroleum-based products for a huge range of sectors, with up to…
News and Trends 26 Jan 2016
Virtual Reality: What is the future of Biotechnology Teaching and Training?
[caption id="attachment_19328" align="alignright" width="205"] Mads Bonde, CEO of Labster[/caption] We often cover cutting-edge advances in biotechnology, but less frequently see…
News and Trends 3 Dec 2015
History of Biotech: How the “First” Biotech Patent Generated Millions
The Cohen-Boyer patents were now issued 35 years ago at Stanford University… so what were they and how did they…
News and Trends 3 Nov 2015
History of Biotech: 25 Years of The Human Genome Project
The birth of the Human Genome Project was now 25 years ago (woah!)...What was the HGP's significance to biotech? What? The…
News and Trends 28 Jul 2015
We met Antoine Hubert, CEO of Ynsect and awarded Innovator Under 35 by the MIT
Each year since 1999, MIT Technology Review, the journal from the top-rank US University, discovers new generations of Innovators Under…
News and Trends 11 May 2015
Ecrins Therapeutics’ first fundraising entirely crowdfunded by WiSEED
Ecrins Therapeutics, the company we interviewed last week, has successfully finished its first crowdfunding fundraiser, reaching €535k on WiSEED’s platform.…
News and Trends 24 Apr 2015
Interview with Dr. Andrei Popov, CEO at Ecrins Therapeutics
Dr. Andrei Popov, CEO at Ecrins Therapeutics Photo credit: Ecrins Therapeutics Laureate of the 2002 INSERM program “Avenir”, Dr. Andrei…
News and Trends 30 Mar 2015
#BioFigures: €406 Million Antibody-drug conjugate Deal struck by ImmunoGen andTakeda
WHO? ImmunoGen is a biotechnology company that develops targeted anticancer therapeutics using its state-of-the-art antibody-drug conjugate (ADC) technology. The Company's uses…
News and Trends 21 Mar 2015
#BioFigures: 12 Key French Players launch New Immunotechnology Reference Center MI-mabs
WHO? MI-mAbs ("MI" for Marseille Immunopole and "mAbs" for monoclonal antibody) is a new immunotechnology center headed by Prof. Francois…
News and Trends 18 Feb 2015
#BioFigures: 3,000 whole genomes sequenced to fight Parkinson!
WHO? 23andMe, founded in 2006, is the leading personal genetics company dedicated to helping people access, understand and benefit from…